Released: 02/09/2009

com:20090902:RnsB3536Y
                                                                                                                       .
RNS Number : 3536Y  
  
Intercytex Group plc  
  
02 September 2009  
  
2 September 2009  
  
Intercytex Group plc  
  
Suspension of trading on AIM  
  
Intercytex Group plc (LSE: ICX) ("Intercytex") today announces temporary 
suspension of trading of its shares on AIM. As a result of the ongoing 
divestment process, the Company will not be in a position to release interim 
financial results before 30 September 2009, and will therefore be suspended from 
trading until such results are released.   
  
The Company remains in advanced discussions with a number of parties to divest 
certain business assets, and will continue to update shareholders on both the 
progress of the strategic review and the potential timing of release of interim 
financial results.   
  
Enquiries  
  
For more information, contact:  
  
 
  Intercytex Group plc                                        
  Nick Higgins, Chief Executive Officer   Tel: 0161 904 4500  
  Max Herrmann, Chief Financial Officer                       
                                                              
  Financial Dynamics                                          
  Jonathan Birt                           Tel: 0207 269 7205  
                                                              
  Piper Jaffray Ltd                                           
  Will Carnwath                           Tel: 0203 142 8700  
  
  
Intercytex' shares trade on AIM, a market of the London Stock Exchange, under 
the ticker symbol ICX.L.  
  
Additional information on the Company can be found at www.intercytex.com  
  
Statements contained within this press release may contain forward-looking 
information or statements with respect to the financial condition, results of 
operations and business achievements/performance of Intercytex and certain of 
the plans and objectives of management of Intercytex with respect thereto. By 
their nature, forward-looking statements involve risks and uncertainties that 
may cause actual results to vary from those contained in the forward-looking 
statements. In some cases, you can identify such forward-looking statements by 
terminology such as 'may', 'will', 'could', 'forecasts', 'expects', 'plans', 
'anticipates', 'believes', 'estimates', 'predicts', 'potential', 'continue' or 
similar expressions. A number of factors, including the satisfactory progress of 
research and development, could cause Intercytex' actual financial condition, 
results of operations and business achievements/performance to differ materially 
from the estimates made or implied in such forward-looking statements and, 
accordingly, reliance should not be placed on such statements. Forward 
projections reflect management's best estimates based on information available 
at the time of issue and are not a guarantee of future performance. Other than 
as required by applicable law, Intercytex does not undertake any obligation to 
update or revise any forward-looking information or statements to reflect events 
or circumstances after the date of this release. The term "Intercytex" refers to 
Intercytex Group plc and its subsidiary undertakings.  
  
 
This information is provided by RNS  
  
The company news service from the London Stock Exchange  
  
  END  
  
SRSILFVEAVILIIA